HDP 000016
Latest Information Update: 13 Oct 2017
At a glance
- Originator Heidelberg Pharma
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Thrombocytopenia
Most Recent Events
- 09 Oct 2017 Heidelberg Pharma is now called Heidelberg Pharma Research
- 31 May 2005 Discontinued - Preclinical for Thrombocytopenia in Germany (unspecified route)
- 02 Sep 2003 Preclinical trials in Thrombocytopenia in Germany (unspecified route)